2019
Novel Use of the Epic Electronic Medical Record Platform to Identify Lost Ureteral Stents
Javier-DesLoges J, Johnson KK, Kenney PA, Motamedinia P. Novel Use of the Epic Electronic Medical Record Platform to Identify Lost Ureteral Stents. Journal Of Endourology 2019, 33: 858-862. PMID: 31418285, DOI: 10.1089/end.2019.0382.Peer-Reviewed Original ResearchConceptsElectronic medical records platformUreteral stent placementUreteral stentsIndependent predictorsEmergent settingBlack raceInsurance statusStent placementMultivariate logistic regressionUreteral stent insertionRecord platformHealth care systemClinical characteristicsMalignant obstructionUreteral injuryPatient chartsSurgical urgencyStent explantationDischarge instructionsStent insertionUreteral stricturePotential complicationsRisk factorsUncertain etiologyUrologic conditions
2015
Can Activities of Daily Living Predict Complications following Percutaneous Nephrolithotomy?
Leavitt DA, Motamedinia P, Moran S, Siev M, Zhao PT, Theckumparampil N, Fakhoury M, Elsamra S, Hoenig D, Smith A, Okeke Z. Can Activities of Daily Living Predict Complications following Percutaneous Nephrolithotomy? Journal Of Urology 2015, 195: 1805-1809. PMID: 26721225, DOI: 10.1016/j.juro.2015.12.076.Peer-Reviewed Original ResearchConceptsCharlson Comorbidity IndexDaily living activitiesPercutaneous nephrolithotomyDaily livingComorbidity indexASA classificationLiving activitiesLength of stayHospital lengthPerioperative outcomesPostoperative complicationsIndependent predictorsPreoperative assessmentFunctional statusOncological surgeryTreatment decisionsDegree of deficitComplicationsNephrolithotomyPatientsSurgeryStayRegression activityDeficitsComplete assessmentThe Expanded Use of Percutaneous Resection for Upper Tract Urothelial Carcinoma: A 30-Year Comprehensive Experience
Motamedinia P, Keheila M, Leavitt DA, Rastinehad AR, Okeke Z, Smith AD. The Expanded Use of Percutaneous Resection for Upper Tract Urothelial Carcinoma: A 30-Year Comprehensive Experience. Journal Of Endourology 2015, 30: 262-267. PMID: 26630130, DOI: 10.1089/end.2015.0248.Peer-Reviewed Original ResearchMeSH KeywordsAdjuvants, ImmunologicAdultAge FactorsAgedAged, 80 and overAntibiotics, AntineoplasticBCG VaccineCarcinoma, Transitional CellDisease ProgressionEndoscopyFemaleHumansKidney NeoplasmsKidney PelvisMaleMiddle AgedMitomycinMultivariate AnalysisNeoplasm GradingNeoplasm Recurrence, LocalNeoplasm StagingNephrectomyRetrospective StudiesRisk FactorsSurvival RateUreterUreteral NeoplasmsConceptsUpper tract urothelial carcinomaBacillus Calmette-GuérinRadical nephroureterectomyOverall survivalUrothelial carcinomaPredictors of OSLow-risk patientsMajority of patientsRisk of deathLow-grade patientsGold standard treatmentHigh-grade patientsMonths of surveillanceResectable diseaseInitial resectionEndoscopic resectionImperative indicationsMedian timeRenal preservationTumor characteristicsAdjuvant rolePercutaneous resectionRetrospective studyPercutaneous managementStandard treatment